Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-21

Clinical Trial Update: The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating glycerol as an optical clearing agent to visualize the middle ear has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycerol (glycerol)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Tympanosclerosis, Thickened Ears | Phase 1 | Status: WITHDRAWN